PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Innovative Public Relations, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Life Sciences, Technology PR Firm Launches New Website GMSInnovate.com - Global Media Strategies offering new online publishing and media relations services
Life Sciences, Technology PR Firm Launches New Website GMSInnovate.com

 

NewswireToday - /newswire/ - Apex, NC, United States, 2011/06/17 - Global Media Strategies offering new online publishing and media relations services.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Innovative online publishing and media relations firm Global Media Strategies has launched its new website, GMSInnovate.com, to promote its new service offerings to businesses and organizations in the life sciences and technology market sectors.

Operating out of the technology-rich Research Triangle Park region of North Carolina, Global Media Strategies helps clients get their brand in front of target audiences in the U.S. and overseas.

“Stricter FDA regulations and oversight are making it tougher for pharmaceutical and biotech companies to deliver their strategic messaging to customers and prospects,” David D. Menzies, president of Global Media Strategies, said, pointing out that heavy fines and even jail time have followed some companies, just for information they have issued in press releases.

The large number of technology startups in the U.S., Asia, and elsewhere are leading to another difficulty, Menzies said, as a shrinking news media and the increased presence of social media are leading to a greater diversity of voices without proper vetting.

“Especially in pharma and general technology, the number of respected news media outlets providing valuable third-party validation of a company’s message is shrinking, while you have more people leveling competing claims that go unchallenged,” he said, adding,“It leads to mass confusion and muddled messaging.”

GMSInnovate.com has information on the proven creative communication tools and methodologies employed by Global Media Strategies to get its clients’ messaging across, highlighting their key differentiators from competitors.

Since 2007, Menzies had been successfully placing clients in major industry publications in such areas as clinical pharmacology, pharmacovigilance, biomedical product manufacturing, healthcare technology, technology transfer, intellectual property law, information technology, software and product design.

About Global Media Strategies
With clients across the United States and overseas, Global Media Strategies (gmsinnovate.com) operates out of the greater Research Triangle Park, N.C. area, a hotbed of innovation and economic growth as well as home to some of the leading life sciences and technology firms in the world. The firm specializes in getting client brands in front of target audiences, utilizing proven effective communication tools and methodologies such as public relations, media relations and online publishing.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Innovative Public Relations, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Life Sciences, Technology PR Firm Launches New Website GMSInnovate.com

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: David Menzies - GMSInnovate.com 
919-274-6862 david[.]gmsinnovate.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Innovative Public Relations, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Innovative Public Relations, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)